Coly Biosystems is a biotechnology company that develops personalized drug delivery systems for targeted therapies.
ColyBio’s primary focus is in oncology using organoid-based platform for optimization of endpoint therapeutics.
Company Details
- Founded
- -
- Address
- Strasbourg, France, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Drug Delivery, Biotechnology, Organoids.
- HQ
- Strasbourg, France
Coly Biosystems Questions
Coly Biosystems's LinkedIn profile is https://fr.linkedin.com/company/colybio
Coly Biosystems's industry is
Biotechnology Research
Coly Biosystems's top competitors are
Elikya Therapeutics,
Iome Bio,
Bio Brasseurs,
Pearl Biosystem,
Proteogenix,
Human Frontier Science Program (Hfsp),
Amc Bio,
Syndivia,
Lamina Therapeutics,
Superbranche.
Coly Biosystems's categories are Biotechnology Research
Coly Biosystems's founding year is 2024
